SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Charles Dadswell as Senior Vice President and General Counsel. Dadswell will assume all functional responsibilities previously held byChristian Cabou, who has retired, and will have worldwide responsibility for all legal and intellectual property matters as well as being Secretary to Illumina’s Board of Directors. […]
BioDiscovery, Inc. a leader in integrated software solutions for genomics data analysis from high-throughput microarray and Next-Gen sequencing technologies, announced today the release of version 7 of Nexus Copy Number software, the leading platform independent and user friendly application for analysis of structural variation from CGH array, SNP array and NGS platforms. Version 7 offers […]
BILLERICA, Mass.– Aushon BioSystems, which provides a range of products and services that drive the development of innovative life sciences diagnostics and therapies, today announced the appointment of Susan Vogt as chief executive officer. Vogt brings more than 30 years of experience in the global life science research, pharmaceutical, biotech and clinical diagnostics markets to […]
SANTA CLARA, Calif — Affymetrix, Inc. (NASDAQ: AFFX) and BioDiscovery announce the availability of the Nexus for OncoScan® Software for analysis of whole genome copy number data generated from formalin-fixed, paraffin-embedded (FFPE) solid tumor samples using the OncoScan® FFPE Express 2.0 Service. Through a joint arrangement, this software, based on BioDiscovery’s flagship Nexus Copy Number™, […]
Lawrenceville, NJ –– Datacolor®, a global leader in color management solutions, today announces that its Datacolor Technology Suzhou laboratory has been accredited by the ANSI-ASQ National Accreditation Board/ACLASS to provide calibration for the International Organization for Standardization / International Electrotechnical Commission (ISO/IEC) 17025:2005. With this accreditation, the Datacolor Technology Suzhou laboratory is now authorized to […]
SANTA CLARA, Calif. — Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. The Company expects to report cash-on-hand of at least $38 million as of March 31, 2013. […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced that its iCOGS custom array was used to identify genetic variants related to breast, ovary and prostate cancer as part of the Collaborative Oncological Gene-Environment Study (COGS), the results of which were published today in Nature Genetics and other leading journals.1 Developed in collaboration with four large […]
Dortmund and Berlin, Germany,: SCIENION AG and France-based Innopsys, a manufacturer of high resolution microarray scanners, today announced a cooperation agreement on a seamless integration of its microarray production and detection equipment. Combining technologies of both companies will benefit our customers for a broad range of applications. A good example is “reverse phase protein array” […]
SANTA CLARA, Calif — Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has signed a contract with UK Biobank to genotype 500,000 DNA samples donated by UK residents as part of a prospective epidemiological study of complex diseases that are of great relevance to public health. Affymetrix’ Axiom® Genotyping Solution will be used to generate […]
ÅS, Norway & SANTA CLARA, Calif. — Aqua Gen, a member of the Erich Wesjohann (EW) Group GmBH and Center for Integrative Genomics (CIGENE) at the Norwegian University of Life Sciences (UMB) in collaboration with Affymetrix, Inc. (NASDAQ: AFFX) announced today that they are the first to genotype more than 900,000 markers per sample from […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
